Infliximab: new indication. Psoriatic arthritis: just another intravenous me-too drug
Prescrire International 16(91): 188
2007
ISSN/ISBN: 1167-7422 PMID: 17926824 Document Number: 612965
Minimal assessment, based on a non comparative prospective cohort study of single-agent therapy.
Document emailed within 1 workday
Related Documents
Lindqvist, U.; Wernroth, M.-L.; Husmark, T.; Larsson, P.; Geijer, M.; Teleman, A.; Theander, E.; Alenius, G.-M. 2017: DAPSA, DAS28 and MDA predict long-term treatment regime in psoriatic arthritis. the Swedish Early Psoriatic Arthritis Cohort Clinical and Experimental Rheumatology 35(6): 936-942Cohen, M.R.; Reda, D.J.; Clegg, D.O. 1999: Baseline relationships between psoriasis and psoriatic arthritis: analysis of 221 patients with active psoriatic arthritis. Department of Veterans Affairs Cooperative Study Group on Seronegative Spondyloarthropathies Journal of Rheumatology 26(8): 1752-1756
Kruse, H.J.; Creutzig, A. 1996: Is there an indication for intravenous iron replacement in, for example, by autologous blood donation-induced iron deficiency and is there a theoretically possible indication for intravenous administration for the not approved Ferrum Hausmann preparation? Der Internist 37(10): 1059
Theiss, B. 1971: Are there typical skin manifestations in psoriatic arthritis and psoriatic spondylarthritis? Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 22(2): 63-68
Salvarani, C.; Lo Scocco, G.; Macchioni, P.; Cremonesi, T.; Rossi, F.; Mantovani, W.; Battistel, B.; Bisighini, G.; Portioli, I. 1995: Prevalence of psoriatic arthritis in Italian psoriatic patients Journal of Rheumatology 22(8): 1499-1503
Patrizi, A.; Venturi, M.; Scorzoni, R.; Pazzaglia, M.; Malavolta, N.; Bardazzi, F. 2014: Nail dystrophies, scalp and intergluteal/perianal psoriatic lesions: risk factors for psoriatic arthritis in mild skin psoriasis? Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 149(2): 177-184
Korendowych, E.; Dixey, J.; Cox, B.; Jones, S.; McHugh, N. 2003: The Influence of the HLA-DRB1 rheumatoid arthritis shared epitope on the clinical characteristics and radiological outcome of psoriatic arthritis Journal of Rheumatology 30(1): 96-101
Jaller Char, J.J.; Jaller, J.A.; Waibel, J.S.; Bhanusali, D.G.; Bhanusali, N. 2018: The Role of IL-17 in the Human Immune System and its Blockage as a Treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Journal of Drugs in Dermatology: Jdd 17(5): 539-542
Manara, M.; Caporali, R.; Favalli, E.G.; Grosso, V.; Atzeni, F.; Sarzi Puttini, P.; Gorla, R.; Bazzani, C.; Fusaro, E.; Pellerito, R.; Rocchetta, P.A.; Sinigaglia, L. 2017: Two-year retention rate of golimumab in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: data from the LORHEN registry Clinical and Experimental Rheumatology 35(5): 804-809
Helliwell, P.S.; Wright, V. 1992: On the postulated co-existence of rheumatoid arthritis and psoriatic arthritis Clinical and Experimental Rheumatology 10(6): 625
Zbojanová, M.; Trnavský, K.; Schultz, P.; Vlcek, F. 1981: The spinal column in psoriatic arthritis and in psoriasis without arthritis Bratislavske Lekarske Listy 75(5): 567-576
Abdelmoula, L.C.; Yahia, C.B.H.; Testouri, N.; Tekaya, R.; Ben M'barek, R.; Chaabouni, L.; Zouari, R. 2008: Treatment of reactive arthritis with infliximab La Tunisie Medicale 86(12): 1095-1097
Allanore, Y.; Sellam, J.; Batteux, F.; Job Deslandre, C.; Weill, B.; Kahan, A. 2004: Induction of autoantibodies in refractory rheumatoid arthritis treated by infliximab Clinical and Experimental Rheumatology 22(6): 756-758
Godinho, F.; Godfrin, B.; El Mahou, S.; Navaux, F.; Zabraniecki, L.; Cantagrel, A. 2004: Safety of leflunomide plus infliximab combination therapy in rheumatoid arthritis Clinical and Experimental Rheumatology 22(3): 328-330
Labarca, Cán.; Massardo, L.; García, P.I.; Jacobelli, S. 2003: Effectiveness of infliximab in patients with inflammatory arthritis refractory to conventional treatment Revista Medica de Chile 131(10): 1157-1164
Becker, M.; Rosé, C.D.; McIlvain-Simpson, G. 2004: Niacin-like reaction to infliximab infusion in systemic juvenile rheumatoid arthritis Journal of Rheumatology 31(12): 2529-2530
True, D.G.; Penmetcha, M.; Peckham, S.J. 2002: Disseminated cryptococcal infection in rheumatoid arthritis treated with methotrexate and infliximab Journal of Rheumatology 29(7): 1561-1563
Tur Kaspa, R.; Ehrenfeld, M.; Eliakim, M. 1979: Psoriatic arthritis Harefuah 96(12): 668-670
Cancelliere, N.; Barranco, P.; Vidaurrázaga, C.; Benito, D.-M.; Quirce, S. 2011: Subacute prurigo and eosinophilia in a patient with rheumatoid arthritis receiving infliximab and etanercept Journal of Investigational Allergology and Clinical Immunology 21(3): 248-249
Henno, A.; Rausin, A.; Malaise, M.; de la Brassinne, M. 2006: Psoriasis and psoriatic arthritis Revue Medicale de Liege 61(5-6): 334-340